-
Mashup Score: 1Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer - PubMed - 2 month(s) ago
The incorporation of immunotherapy into the initial treatment for advanced and metastatic endometrial cancer brings about a substantial improvement in oncologic outcomes, especially within the MMRd/MSI-H subset. This specific subgroup is currently a focal point of investigation for evaluating the po …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1January is OASIs Awareness Month - 3 month(s) ago
Details Published: Monday, January 01, 2024 January marks Obstetric Anal Sphincter Injuries (OASIs) Awareness Month, a time to raise awareness about a crucial yet often overlooked aspect of maternal health. Join us in promoting understand ing, prevention, and support for those affected by OASIs. Together, let’s foster a community that prioritizes the well-being of mothers and advocates for comprehensive healthcare! What are Obstetric Anal Sphincter Injuries (OASIs)? OASIs, also known as a third- or
Source: www.iuga.orgCategories: General Medicine News, Hem/OncsTweet-
RT @globalgyno: January is OASIs Awareness Month https://t.co/5TqsaAikdx
-
-
Mashup Score: 0Opinion | I Cannot Remember the Names of Biologics. Should I Retire? - 8 month(s) ago
The old days of drug nomenclature were simpler
Source: www.medpagetoday.comCategories: Latest Headlines, Oncologists1Tweet-
Opinion | I Cannot Remember the Names of Biologics. Should I Retire? https://t.co/LxkE4cgN84
-
-
Mashup Score: 0Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report - 1 year(s) ago
The original vision of the field of gynecologic oncology was to establish a multidisciplinary approach to the management of patients with gynecologic …
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet-
Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report - ScienceDirect #sgomeeting https://t.co/ZZYpnqMdVp
-
-
Mashup Score: 0Baskets for Babies - 1 year(s) ago
I’m a proud supporter of Nuvance Health. Learn more about their event Baskets for Babies : https://fundraise.givesmart.com/e/h4PD_A
Source: fundraise.givesmart.comCategories: Hem/Oncs, Latest HeadlinesTweet-
I’m a proud supporter of Villanova women’s basketball Baskets for Babies fundraiser. Every dollar raised goes to the expansion of the VBMC NICU. Please consider supporting their efforts – and help spread the word: https://t.co/0MrkxU2QsD. #nuvancehealth
-
-
Mashup Score: 1Baskets for Babies - 1 year(s) ago
I’m a proud supporter of Nuvance Health. Learn more about their event Baskets for Babies : https://fundraise.givesmart.com/e/h4PD_A
Source: fundraise.givesmart.comCategories: Hem/Oncs, Latest HeadlinesTweet-
I’m a proud supporter of Villanova women’s basketball Baskets for Babies fundraiser – championed by Poughkeepsie’s own Villanova forward Maddy Siegrist. Please consider supporting their efforts for Vassars NICU – and help spread the word: https://t.co/qyuFClJbq2
-
-
Mashup Score: 0
Our findings showed that there is no reasonable operative time at which total laparoscopic hysterectomy is associated with a higher rate of complications or longer length of stay than total abdominal hysterectomy.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#aagl there is no reasonable operative time at which total laparoscopic #hysterectomy is associated with a higher rate of complications or longer length of stay than total abdominal hysterectomy. https://t.co/rdony1bTYN
-
-
Mashup Score: 1Any Mountain Everest - 1 year(s) ago
Event Home Donate Register Sponsors Merchandise …
Source: Any Mountain EverestCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @StephanieVBlank: Any Mountain Everest https://t.co/WIqCs0t6ea #
-
-
Mashup Score: 0
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update OR was 39.8% and the median DOR was 22.9 months #endometrialcancer https://t.co/DZPR9bXtrN
-
-
Mashup Score: 0
PURPOSE To report clinical and treatment characteristics, remission and failure patterns, and risk factors for local failure (LF) from the EMBRACE-I study. MATERIALS AND METHODS EMBRACE-I was a prospective, observational, multicenter cohort study on magnetic resonance imaging–based image-guided adaptive brachytherapy (MR-IGABT) in locally advanced cervical cancer. Treatment consisted of external…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image–Guided Brachytherapy in Locally Advanced Cervical Cancer: 95% LC 3 years postintervention for squamous cell in comparison to 86% for adeno/adenosquamous #cervicalcancer https://t.co/raQi1LoesZ
-
RT @GynCancerMD: https://t.co/7bPSuuPnsR Fortunate to work amazing colleagues and friends.